In a pair of recent warning letters, the Food and Drug Administration says Chinese syringe makers Jiangsu Shenli and Jiangsu Caina are in violation of quality system regulations following inspections of both companies.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?